Literature DB >> 33338116

Reactivation of Chagas disease after autologous hematopoietic stem cell transplantation.

Claudia Marcela Chalela1, Angela Maria Peña1,2, Angela Maria Roa1, David L Reyes1, Jennifer Paola Rueda1, Luis Antonio Salazar1,2, Manuel Rosales2, Edgar David Gomez1,3, Edgar Augusto Bernal4, Claudia Lucia Sossa Melo1,2.   

Abstract

Chagas disease (CD) is a protozoan zoonosis caused by Trypanosoma cruzi. Reactivation of CD occurs via drug-induced immunosuppression before and during transplantation. Here, we report the case of a 62-year-old man diagnosed with classic Hodgkin lymphoma who received highly aggressive conditioning chemotherapy before undergoing stem cell transplantation (SCT). The patient tested positive for CD in pre-transplantation evaluation. The patient exhibited persistent fever and elevated C-reactive protein levels before and after SCT, and was treated with antibiotics. Micro-Strout test showed evidence of trypomastigotes and he was treated with benznidazole until tested negative. Post-transplantation seropositive patients should be screened for possible reactivation.

Entities:  

Year:  2020        PMID: 33338116     DOI: 10.1590/0037-8682-0143-2020

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  1 in total

1.  Chagas disease reactivation after autologous stem cell transplant. Case report and literature review

Authors:  Juan David Rojas; Mario Pereira; Bibiana Martínez; Julio César Gómez; Sonia Isabel Cuervo
Journal:  Biomedica       Date:  2022-06-01       Impact factor: 1.173

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.